» Articles » PMID: 19387921

Role of Alcohol in Liver Carcinogenesis

Overview
Journal Semin Liver Dis
Publisher Thieme
Specialty Gastroenterology
Date 2009 Apr 24
PMID 19387921
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in the world and contributes significantly to cancer-related morbidity and mortality. Chronic alcohol consumption has long been associated with progressive liver disease toward the development of hepatic cirrhosis and the subsequent increased risk for developing HCC. In assessing the role of alcohol during hepatic disease, and as a carcinogen, many of the deleterious effects of alcohol can be attributed to alcohol metabolism in hepatocytes. In addition to the direct effects of alcohol/alcohol metabolism on hepatocyte transformation, increasing evidence indicates that other intrahepatic and systemic effects of alcohol are likely to play an equally significant role in the process of hepatic tumorigenesis.

Citing Articles

AKR7A5 knockout promote acute liver injury by inducing inflammatory response, oxidative stress and apoptosis in mice.

Shi H, Xu W, Liu Q, Li Y, Dong S, Zhao Z J Cell Mol Med. 2024; 28(19):e70129.

PMID: 39365156 PMC: 11451264. DOI: 10.1111/jcmm.70129.


Tumor Growth in Overdrive: Detailing an Aggressive Course of Hepatocellular Carcinoma.

Singh S, Delungahawatta T, Wolff M, Haas C Case Reports Hepatol. 2024; 2024:4950398.

PMID: 38974801 PMC: 11226333. DOI: 10.1155/2024/4950398.


British Society of Gastroenterology guidelines for the management of hepatocellular carcinoma in adults.

Suddle A, Reeves H, Hubner R, Marshall A, Rowe I, Tiniakos D Gut. 2024; 73(8):1235-1268.

PMID: 38627031 PMC: 11287576. DOI: 10.1136/gutjnl-2023-331695.


Alcohol-Associated Liver Disease: Evolving Concepts and Treatments.

Prince D, Nash E, Liu K Drugs. 2023; 83(16):1459-1474.

PMID: 37747685 PMC: 10624727. DOI: 10.1007/s40265-023-01939-9.


The effect of liver disease on hepatic microenvironment and implications for immune therapy.

Brown Z, Ruff S, Pawlik T Front Pharmacol. 2023; 14:1225821.

PMID: 37608898 PMC: 10441240. DOI: 10.3389/fphar.2023.1225821.